The Stem Cell Network North Rhine-Westphalia is a non-profit association founded by 19 scientific institutions in NRW in September 2018. Prior to this, the network had already existed for 16 years under the German name “Kompetenznetzwerk Stammzellforschung NRW”, always supported by the Ministry of Science (currently the Ministry of Culture and Science) of the State of NRW.
The association has three bodies (General Assembly, Board of Representatives, and Executive Board), as well as advisory bodies (Board of Trustees and Advisory Board), and an office.
The General Assembly consists of at least one representative of each member. The network currently has 23 members (legal entities), for whom the legal representative (rector or medical director) or a representative appointed by the rector or medical director participates in the meeting of the General Assembly.
According to the statutes of the Stem Cell Network NRW, various tasks of the General Assembly were transferred to the Board of Representatives. In contrast to the General Assembly, it does not consist of legal entities, but of natural persons. The General Assembly elects the Board of Representatives. It also determines how many people it should consist of; the number of persons is currently 23 which have 27 votes:
The Executive Board conducts the business of the association, including its judicial and extrajudicial representation. It consists of eight members. The Board of Representatives elects the Executive Board, which consists of the two spokespersons of the Board of Representatives, one member each from the fields of ethical legal and social aspects (ELSA) and biomedicine, as well as four other persons from other fields.
The Board of Trustees consists of five members and advises the General Assembly and the other bodies of the association within the scope of their respective responsibilities. It consists of a representative of the State of North Rhine-Westphalia and one representative each in the fields of (i) biomedicine, (ii) ELSA, (iii) industrial applications, and (iv) public research funding.
Heinrich Heine University Düsseldorf
Representative Industrial Applications
Miltenyi Biotec GmbH
Representative Project Management Agency
Project Management Organisation Jülich
Representative of the State of North Rhine-Westphalia
Ministry of Culture and Science of the State of North Rhine-Westphalia
The Advisory Board consists of personalities from public life, who can make contributions due to their own expertise and references to the topic. The members of the Advisory Board are representatives from the fields of science and clinic, politics, regulation and law, religion and belief, patient representatives, and industry.
Representative Science and Clinic
University Hospital Tübingen
Federal Ministry of Education and Research
Representative Patients' Interests
Representative of the state government for people with disabilities and patients in North Rhine-Westphalia
Chairperson of the Advisory Board
AiCuris GmbH & Co. KG
Representative Regulation & Law
University of Mannheim
Representative Science and Clinic
German Cancer Research Center
The ELSA working group (ethical, legal, and social aspects) is composed of experts from philosophy, theology, law, and social sciences. It addresses matters such as the legal framework of stem cell research or the ethical and social scientific assessment of new stem cell-related scientific findings and methods.
The office supports the bodies of the association in implementing the stated goals and putting in place the proposed measures. The team consists of the managing director, a science manager, an event management and communications officer, and a finance and procurement officer.